Human african trypanosomiasis

P Büscher, G Cecchi, V Jamonneau, G Priotto - The Lancet, 2017 - thelancet.com
Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost
invariably progresses to death unless treated. Human African trypanosomiasis caused …

Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics

A Talevi, CL Bellera - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Drug repurposing (also known as drug repositioning, drug reprofiling, indication expansion
or indication shift) involves establishing new medical uses for already known drugs …

Nitro-group-containing drugs

K Nepali, HY Lee, JP Liou - Journal of medicinal chemistry, 2018 - ACS Publications
The nitro group is considered to be a versatile and unique functional group in medicinal
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …

The animal trypanosomiases and their chemotherapy: a review

F Giordani, LJ Morrison, TG Rowan, HP De Koning… - Parasitology, 2016 - cambridge.org
Pathogenic animal trypanosomes affecting livestock have represented a major constraint to
agricultural development in Africa for centuries, and their negative economic impact is …

An update on African trypanocide pharmaceutics and resistance

KI Kasozi, ET MacLeod, I Ntulume… - Frontiers in Veterinary …, 2022 - frontiersin.org
African trypanosomiasis is associated with Trypanosoma evansi, T. vivax, T. congolense,
and T. brucei pathogens in African animal trypanosomiasis (AAT) while T. b gambiense and …

The drugs of sleeping sickness: their mechanisms of action and resistance, and a brief history

H P. De Koning - Tropical Medicine and Infectious Disease, 2020 - mdpi.com
With the incidence of sleeping sickness in decline and genuine progress being made
towards the WHO goal of eliminating sleeping sickness as a major public health concern …

[图书][B] The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th …

Organisation mondiale de la santé. Comité d'experts … - 2015 - books.google.com
This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …

[HTML][HTML] Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis

LM Alcântara, TCS Ferreira, FR Gadelha… - International Journal for …, 2018 - Elsevier
Tritryps diseases are devastating parasitic neglected infections caused by Leishmania spp.,
Trypanosoma cruzi and Trypanosoma brucei subspecies. Together, these parasites affect …

A phase I trial of DFMO targeting polyamine addiction in patients with relapsed/refractory neuroblastoma

GL Saulnier Sholler, EW Gerner, G Bergendahl… - PloS one, 2015 - journals.plos.org
Background Neuroblastoma (NB) is the most common cancer in infancy and most frequent
cause of death from extracranial solid tumors in children. Ornithine decarboxylase (ODC) …

The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration

KM Pfarr, AK Krome, I Al-Obaidi, H Batchelor… - Parasites & …, 2023 - Springer
Abstract The World Health Organization 'Ending the neglect to attain the Sustainable
Development Goals: A road map for neglected tropical diseases 2021–2030'outlines the …